Some research community protocols stack 5-Amino-1MQ with AOD-9604 or with a GLP-1 drug, but no human study has tested those combinations
Nausea 15-44%, vomiting 5-24%
Not licensed for human use in the UK AOD-9604: Not approved for any medical use
It also inhibits pro-inflammatory cytokines, such as IL-1 and TNF-, giving it an edge in chronic inflammatory conditions
Fjell, C.D., Hiss, J.A., Hancock, R.E., and Schneider, G., Nat
Peptide therapy may be considered for patients who are looking for support with: Recovery from musculoskeletal stress Soft tissue healing Skin and tissue rejuvenation Performance recovery Active aging and wellness optimization Cellular support as part of a broader regenerative strategy If you are an active adult, athlete, wellness-focused patient, or someone looking for non-surgical options to support recovery and vitality, the GLOW Protocol may be worth discussing with our medical team